Study guide
7.3 PCR Inhibition, Facilitators & Troubleshooting
ASCP Molecular Biology Technologist MB
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Strategy
1.1 ASCP MB Exam Structure, Eligibility Routes & Policies 1.2 Computer Adaptive Testing (CAT) & Scoring Mechanics 1.3 Blueprint Navigation & Preparation Strategy
2 Nucleic Acid Chemistry & Molecular Structure
2.1 DNA Structure, Nitrogenous Bases & Thermodynamic Stability 2.2 RNA Types, Secondary Structure & Chemical Lability 2.3 Chromatin Organization, Histone Modifications & DNA Methylation
3 Central Dogma, Genome Organization & Cytogenetics
3.1 DNA Replication Machinery & Enzymology 3.2 Transcription, Translation & Genetic Code 3.3 Mutations, Polymorphisms & Chromosomal Aberrations
4 Biochemical Reagents & Enzymes
4.1 DNA Polymerases, Reverse Transcriptases & Proofreading 4.2 Restriction Endonucleases, Ligases & Nucleases 4.3 Reaction Buffers, Cations & Master Mix Additives
5 Nucleic Acid Isolation & Purification
5.1 Organic & Inorganic Extraction Chemistries 5.2 Solid-Phase Silica Columns & Magnetic Bead Isolation 5.3 Specimen-Specific Lysis & Challenging Matrices
6 Nucleic Acid Quantification & Electrophoresis
6.1 UV Spectrophotometry & Fluorometry 6.2 Agarose & Polyacrylamide Gel Electrophoresis 6.3 Capillary Electrophoresis & Microfluidic Bioanalyzers 6.4 Mass Spectrometry (MALDI-TOF) in Molecular Diagnostics
7 PCR Principles & Primer Design Optimization
7.1 Conventional PCR Thermodynamics & Cycling Kinetics 7.2 Primer Design Criteria, Melting Temp & Secondary Structures 7.3 PCR Inhibition, Facilitators & Troubleshooting
8 Advanced Amplification Technologies
8.1 Real-Time qPCR Probe Chemistries & Fluorescent Dyes 8.2 qPCR Quantification (Standard Curve, ΔΔCt) & Dissociation Melt Curve Analysis 8.3 Digital PCR (dPCR), Droplet Partitioning & Poisson Absolute Quantification 8.4 Isothermal & Target Multiplex Amplification
9 DNA Sequencing Technologies
9.1 Sanger Dideoxy Sequencing & Electropherogram Interpretation 9.2 NGS Library Preparation, Fragmentation & Target Enrichment 9.3 Massively Parallel NGS Platforms & Chemistries 9.4 NGS Quality Metrics, Coverage Depth & Bioinformatics
10 Hybridization, Blotting & Cytogenetic Assays
10.1 Southern, Northern & Dot Blot Chemistries 10.2 Fluorescence In Situ Hybridization (FISH) & CISH 10.3 Microarrays & Array Comparative Genomic Hybridization (aCGH)
11 Molecular Infectious Disease Diagnostics
11.1 Quantitative Viral Load Monitoring (HIV-1, HCV, HBV, CMV) 11.2 Qualitative Multiplex Syndromic Pathogen Panels 11.3 Antimicrobial Resistance Genotyping 11.4 Molecular Epidemiology & Pathogen Typing
12 Molecular Oncology & Hematopathology
12.1 Hematologic Malignancies & Translocation Assays 12.2 Solid Tumor Somatic Driver Mutations 12.3 Microsatellite Instability & DNA Mismatch Repair 12.4 Liquid Biopsy, ctDNA & Minimal Residual Disease
13 Medical Genetics, Pharmacogenomics & Identity Testing
13.1 Single-Gene Mendelian Disorders & CFTR Testing 13.2 Trinucleotide Repeat Expansion Disorders 13.3 Clinical Pharmacogenomics (PGx) Core Alleles 13.4 Human Identity Testing & Post-Transplant Chimerism
14 Quality Assurance, Controls & Method Validation
14.1 Quality Assurance Controls & Reference Materials 14.2 Clinical Method Validation & Performance Characteristics 14.3 Quality Management, Proficiency Testing & Competency
15 Laboratory Operations, Safety & Clinical Variant Reporting
15.1 Physical Facility Design & Unidirectional Workflow 15.2 Laboratory Biosafety, Chemical Hygiene & Waste 15.3 Clinical Calculations, ACMG Variant Classification & HGVS
7.3 PCR Inhibition, Facilitators & Troubleshooting
Key Takeaways Explain This Topic AI
Endogenous clinical PCR inhibitors include heme/hematin (blood, Mg2+ chelation), heparin (competitive polyanion polymerase blocker, treated with Heparinase I), melanin (tissue), bile salts (stool), and formalin crosslinks (FFPE).
Exogenous extraction carryover inhibitors include phenol (>=0.2% v/v), SDS (>=0.01% w/v), and ethanol (>=1% v/v), which denature or precipitate Taq DNA polymerase.
Chemical facilitators rescue difficult reactions: Betaine (1.0–2.5 M) and DMSO (2%–10%) resolve GC-rich secondary structures, BSA (0.1–0.5 mg/mL) scavenges heme/melanin, and non-ionic detergents neutralize SDS.
Hot-start polymerases (antibody-mediated, chemically-modified, or aptamer-based) prevent room-temperature mispriming and primer-dimer formation during pre-PCR setup.
Systematic troubleshooting relies on Internal Amplification Controls (IAC) to differentiate true biological negatives from complete inhibition, supported by physical unidirectional workflow and the dUTP/UNG carryover prevention system.
Last updated: August 2026
7.3 PCR Inhibition, Facilitators & Troubleshooting
Quick Summary: Diagnostic accuracy in clinical molecular pathology depends on identifying, mitigating, and troubleshooting PCR inhibition and reaction failure. Clinical specimens contain potent endogenous inhibitors—such as heme/hematin in blood, heparin in anticoagulant tubes (a competitive DNA-mimicking polyanion remediated by Heparinase I ), melanin in melanoma tissues, bile salts/bilirubin in stool, and formalin-induced crosslinks in FFPE specimens—as well as exogenous extraction carryovers ( phenol, SDS, ethanol, guanidinium thiocyanate ). Chemical facilitators and additives—including betaine and DMSO (to destabilize GC-rich secondary structures), Bovine Serum Albumin (BSA) (to scavenge heme/melanin), and non-ionic detergents ( Tween-20/Triton X-100 )—rescue compromised reactions. Master mix optimization with Hot-Start DNA polymerases (antibody- or chemical-mediated) suppresses room-temperature mispriming. Robust clinical quality systems mandate an Internal Amplification Control (IAC) to definitively discriminate true biological negative results from complete reaction inhibition, combined with strict physical unidirectional workflow and the dUTP/Uracil-N-Glycosylase (UNG) system to eliminate amplicon carryover contamination.
1. Clinical PCR Inhibitors & Biochemical Mechanisms of Action
PCR inhibition occurs when chemical substances in clinical lysates interfere with DNA polymerase function, chelate essential metal cofactors, or degrade nucleic acid templates. MECHANISMS OF CLINICAL PCR INHIBITION
- [ 1. Magnesium Chelation ] [ 2. Competitive Polymerase Binding ]
- EDTA, Heme, high dNTPs - Heparin (polyanion), Humic acids
- Depletes free catalytic Mg2+ - Displaces DNA from polymerase active site
- \ /
- v v
- +------------------------------------+
- | PCR REACTION ARREST / FAILURE |
- +------------------------------------+
- ^ ^
- / \
- [ 3. Enzyme Denaturation / Degradation ] [ 4. Template Crosslinking / Inaccessibility ]
- Phenol, SDS, Urea, Proteases - Formalin / Paraffin (FFPE), Melanin
- Destroys polymerase tertiary structure - Physically blocks strand separation & extension
- Comprehensive Clinical Inhibitor Diagnostic Matrix
Inhibitor Class Clinical Specimen / Source Primary Biochemical Mechanism of Action Detection Profile & Threshold Remediation / Laboratory Rescue Strategy
Heme / Hematin / Hemoglobin Whole blood, bone marrow aspirates, bloody CSF Chelates catalytic Mg 2 + \text{Mg}^{2+} Mg 2 + ; directly binds Taq polymerase; quenches qPCR fluorescence. Inhibits Taq at > 0.8 μ M >0.8\text{ }\mu\text{M} > 0.8 μ M hematin; brownish lysate. Add Bovine Serum Albumin (BSA, 0.1 – 0.5 mg/mL 0.1–0.5\text{ mg/mL} 0.1–0.5 mg/mL ) ; use inhibition-tolerant polymerases ( KAPA2G , OmniTaq ); perform 1:10 sample dilution.
Heparin Green-top blood collection tubes Highly sulfated polyanion structurally mimics DNA backbone; competitively binds Taq active site. Complete reaction arrest at > 0.02 IU/mL >0.02\text{ IU/mL} > 0.02 IU/mL . Treat template with Heparinase I ( 37 ∘ C 37^\circ\text{C} 3 7 ∘ C for 1 hr); re-precipitate with lithium chloride ( L i C l LiCl L i Cl ); collect blood in purple-top K 2 EDTA K_2\text{EDTA} K 2 EDTA tubes.
EDTA Excessive anticoagulant in purple-top tubes; elution buffer carryover Strongly chelates divalent Mg 2 + \text{Mg}^{2+} Mg 2 + cofactors ( log K f ≈ 8.7 \log K_f \approx 8.7 lo g K f ≈ 8.7 ), depriving Taq active site of magnesium. Inhibits when [ EDTA ] ≥ [ Mg 2 + ] [\text{EDTA}] \ge [\text{Mg}^{2+}] [ EDTA ] ≥ [ Mg 2 + ] . Titrate supplemental MgCl 2 \text{MgCl}_2 MgCl 2 into master mix ( + 1.0 – 2.0 mM +1.0 – 2.0\text{ mM} + 1.0–2.0 mM ); elute DNA in low-EDTA ( 0.1 mM 0.1\text{ mM} 0.1 mM ) or 10 mM 10\text{ mM} 10 mM Tris-HCl (pH 8.0).
Melanin Melanoma skin biopsies, hair, pigmented tissues Thermally stable polyaromatic pigment co-purifies with DNA; directly binds Taq and blocks extension. Inhibits at > 0.2 μ g/mL >0.2\text{ }\mu\text{g/mL} > 0.2 μ g/mL ; brownish-black DNA pellet. Add BSA ( 0.4 mg/mL 0.4\text{ mg/mL} 0.4 mg/mL ) ; pass lysate through polyvinylpyrrolidone (PVPP) spin column; 1:10 dilution.
Bile Salts & Bilirubin Stool specimens, duodenal aspirates, liver biopsies Bile salts (sodium deoxycholate) denature polymerase; bilirubin degrades nucleic acids. Severe inhibition in crude stool extracts. Stool DNA extraction kits with dedicated inhibitor-adsorption matrix (InhibitEX); sample dilution.
Urea Urine specimens Disrupts hydrogen bonds and hydrophobic interactions, denaturing Taq polymerase tertiary structure. Inhibits at > 20 mM >20\text{ mM} > 20 mM urea. Centrifuge urine to pellet cellular sediment; wash pellet with PBS before lysis; silica-column purification.
Humic & Fulvic Acids Soil, environmental swabs, forensic trace evidence Phenolic polyanions that bind DNA and inactivate polymerases. Dark coloration; inhibits at nanogram levels. PVPP chromatography; add BSA or gelatin; robust solid-phase bead wash.
Formalin / FFPE Artifacts Formalin-Fixed Paraffin-Embedded tissues Methylene bridge crosslinks ( − CH 2 − -\text{CH}_2- − CH 2 − ) between DNA and proteins; cytosine deamination ( C → U C \rightarrow U C → U ). Severely fragmented DNA ( < 200 bp <200\text{ bp} < 200 bp ); delayed qPCR C t C_t C t . Extended Proteinase K digestion; heat-mediated de-crosslinking ( 90 ∘ C 90^\circ\text{C} 9 0 ∘ C for 1 hr); treat with Uracil-DNA Glycosylase (UDG) to eliminate deaminated C → T C \rightarrow T C → T artifacts.
Phenol Carryover Organic liquid-liquid extraction (PCI) Organic solvent denatures Taq polymerase active site. Complete inhibition at ≥ 0.2 % v/v \ge 0.2\%\text{ v/v} ≥ 0.2% v/v ; A 260 / A 280 < 1.6 A_{260}/A_{280} < 1.6 A 260 / A 280 < 1.6 . Perform secondary chloroform wash; repeat 70% ethanol wash of DNA pellet; silica spin-column cleanup.
SDS (Sodium Dodecyl Sulfate) Cell lysis buffers Strong ionic detergent disrupts hydrophobic core of DNA polymerase. Potent inhibition at ≥ 0.01 % w/v \ge 0.01\%\text{ w/v} ≥ 0.01% w/v . Add non-ionic detergents ( 0.5 % Tween-20 0.5\%\text{ Tween-20} 0.5% Tween-20 or 0.5 % Triton X-100 0.5\%\text{ Triton X-100} 0.5% Triton X-100 ) to neutralize SDS.
Ethanol / Isopropanol Extraction wash buffers Alcohols denature polymerases and precipitate reagents. Inhibits at ≥ 1.0 % v/v \ge 1.0\%\text{ v/v} ≥ 1.0% v/v . Dry silica spin-column membranes completely ( 14 , 000 × g 14,000 \times g 14 , 000 × g for 2–3 min) before adding elution buffer.
2. Chemical Facilitators & Master Mix Additives
When amplifying difficult GC-rich templates ( > 65 % GC >65\%\text{ GC} > 65% GC ), templates with stable stem-loop secondary structures, or specimens containing residual inhibitors, adding chemical co-solvents and facilitators rescues the reaction. +---------------------------------------------------------------------------------------------------+
- | PCR FACILITATORS & REACTION ENHANCERS |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- | Facilitator / | Working | Biophysical | Specific Clinical | Potential Hazard /|
- | Additive | Concentration | Mechanism | Application | Caution |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- | **Betaine** | **$1.0 – 2.5\text{ M}$**| Zwitterionic osmolyte| **GC-rich templates**| High concentration|
- | ($N,N,N$-trimethyl| | equalizes hydra- | (*FMR1*, *HTT*, | ($>3\text{ M}$) |
- | glycine) | | tion free energy of| *C9orf72* repeat | reduces polymerase|
- | | | AT vs GC base pairs| expansion assays) | activity |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- | **Dimethyl | **$2\% – 10\%$** | Polar aprotic | **GC-rich PCR**; | **Lowers $T_m$ by |
- | **Sulfoxide (DMSO)**| (v/v) | solvent disrupts | reduces hairpin | $5.5^\circ\text{C}$ per 10%**;|
- | | | interstrand H-bonds| formation | $>10\%$ inhibits |
- | | | | | Taq activity |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- | **Bovine Serum | **$0.1 – 0.5\text{ mg/mL}$**| Scavenger protein | **Blood & tissue**| Must be nuclease- |
- | **Albumin (BSA)** | (or $0.01–0.05\%$)| binds & neutralizes| PCR; neutralizes | free (non-acetyl- |
- | | | heme, melanin, and| residual hematin | ated) |
- | | | polyphenols | and humic acids | |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- | **Formamide** | **$1.25\% – 5\%$**| Organic denaturant| Increases | Toxic teratogen; |
- | | (v/v) | lowers melting | stringency; | lowers $T_m$ |
- | | | temperature | resolves GC stems | ($0.6^\circ\text{C}/\%$) |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- | **Glycerol** | **$5\% – 10\%$** | Polyol cosolvent | Stabilizes *Taq* | Increases reaction|
- | | (v/v) | lowers $T_m$ and | enzyme; enhances | viscosity |
- | | | stabilizes enzyme | long amplicons | |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- | **Non-Ionic | **$0.1\% – 1.0\%$**| Neutralizes ionic | Overcomes residual| Excess causes |
- | **Detergents** | (v/v) | charges on SDS | lysis detergent | foaming during |
- | (Tween-20, NP-40) | | detergent micelles| carryover | liquid handling |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- The Thermodynamics of Betaine & DMSO in GC-Rich Amplification
In high GC-content amplicons ( > 65 – 70 % GC >65–70\%\text{ GC} > 65–70% GC , such as FMR1 Fragile X CGG trinucleotide repeats or EGFR GC-rich exons):
Strong GC base stacking and triple hydrogen bonding create thermal melting temperatures exceeding 95 ∘ C 95^\circ\text{C} 9 5 ∘ C , preventing complete denaturation during standard cycling.
Single-stranded templates rapidly fold into ultra-stable intrastrand hairpins and G-quadruplex structures that stall Taq polymerase, causing premature abortive termination.
Betaine ( 1.0 – 2.0 M 1.0–2.0\text{ M} 1.0–2.0 M ) acts as an isostabilizing agent, reducing the sequence-dependent melting temperature variation between GC and AT pairs, effectively "flattening" the thermodynamic barrier across the template.
DMSO ( 5 % 5\% 5% ) weakens hydrogen bonds, lowering the overall duplex melting temperature by approximately 5.5 ∘ C 5.5^\circ\text{C} 5. 5 ∘ C to 6.0 ∘ C 6.0^\circ\text{C} 6. 0 ∘ C for every 10 % 10\% 10% added .
3. Hot-Start PCR Chemistries & Non-Specific Priming Control
At ambient room temperature ( 20 ∘ C– 25 ∘ C 20^\circ\text{C}–25^\circ\text{C} 2 0 ∘ C –2 5 ∘ C ) during pre-PCR reaction setup, wild-type Taq DNA polymerase retains approximately 1 % – 5 % 1\%–5\% 1%–5% basal catalytic activity . At these permissive temperatures, primers bind non-specifically to off-target genomic sequences and hybridize to each other at their 3 ′ 3' 3 ′ ends. Taq polymerase extends these misprimed complexes, generating non-specific amplicons and primer-dimers that outcompete the intended target during subsequent thermal cycling. HOT-START POLYMERASE ACTIVATION
- [ Room Temp Setup (20°C - 25°C) ] [ Initial Denaturation (95°C for 2 - 10 min) ]
- Enzyme is INACTIVE / BLOCKED Thermal Activation releases Functional Enzyme
- A. Antibody-Mediated: A. Antibody denatures irreversibly
- Taq + Monoclonal Anti-Taq Ab ------------> Free, active Taq Polymerase
- B. Chemically-Modified (AmpliTaq Gold): B. Labile chemical crosslinks hydrolyze
- Taq with Lysine chemical adducts --------> Fully active recombinant Taq
- C. Aptamer-Mediated: C. Aptamer hairpin denatures & releases Taq
- Taq + Synthetic Oligo Aptamer -----------> Reversible activation at >45°C - 50°C
- Hot-Start Formulation Comparison
Antibody-Mediated Hot-Start : A neutralizing monoclonal antibody is bound to the polymerase active site. Activation requires only 1 – 3 minutes 1–3\text{ minutes} 1–3 minutes at 95 ∘ C 95^\circ\text{C} 9 5 ∘ C (the antibody denatures rapidly). Ideal for fast-cycling qPCR and multiplex assays.
Chemically-Modified Hot-Start (e.g., AmpliTaq Gold) : Dicarboxylic anhydride groups are covalently linked to lysine ε \varepsilon ε -amino residues in the active site. Activation requires a prolonged 10 – 15 minute 10–15\text{ minute} 10–15 minute heat soak at 95 ∘ C 95^\circ\text{C} 9 5 ∘ C to hydrolyze the covalent bonds and restore enzyme activity.
Aptamer-Mediated Hot-Start : A synthetic nucleic acid aptamer binds tightly to Taq at low temperatures and dissociates reversibly at temperatures above 45 ∘ C– 50 ∘ C 45^\circ\text{C}–50^\circ\text{C} 4 5 ∘ C –5 0 ∘ C , providing rapid activation without extended denaturation.
4. Comprehensive Clinical PCR Troubleshooting Guide
When a clinical molecular diagnostic assay generates abnormal results, the technologist must execute systematic root-cause analysis based on control performance and electropherogram/gel band patterns. +---------------------------------------------------------------------------------------------------+
- | PCR TROUBLESHOOTING LOGIC MATRIX |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- | Observed Clinical | Positive Control | Negative Control | Internal Amplifi- | Root Cause & |
- | Problem / Pattern | (PC) Status | (NTC) Status | cation Control | Remediation |
- | | | | (IAC) in Sample | Action |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- | **1. Complete No- | **Failed** | Clean | Failed | **Master mix / |
- | Amplification** | (No band) | (No band) | (No band) | thermal failure.**|
- | (All tubes blank) | | | | Reagent omitted |
- | | | | | ($\text{Mg}^{2+}$, dNTPs, enzyme)|
- | | | | | or cycler crash. |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- | **2. Sample Fails;| **Passed** | Clean | **FAILED** | **TRUE PCR |
- | PC Normal** | (Sharp band) | (No band) | (No band) | INHIBITION.** |
- | (Target & IAC | | | | Inhibitor present |
- | both blank) | | | | in sample lysate. |
- | | | | | Dilute 1:10, BSA. |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- | **3. True Biologi-| **Passed** | Clean | **PASSED** | **TRUE NEGATIVE.**|
- | cal Negative** | (Sharp band) | (No band) | (Sharp band) | Sample lacks |
- | (Target blank, | | | | target DNA; assay |
- | IAC present) | | | | is fully valid. |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- | **4. Non-Specific | Passed | Clean | Passed | **Annealing $T_a$ |
- | Multiple Bands / | (Target + extra) | (No band) | | too low; excess |
- | Smearing** | | | | $\text{Mg}^{2+}$; no hot-start.**|
- | | | | | Raise $T_a$, TD-PCR.|
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- | **5. Severe | Passed or Weak | Present in NTC | Passed | **Excess primers; |
- | Primer-Dimers** | (Strong dimer) | (Strong dimer) | | $3'$ complementarity;|
- | ($<100\text{ bp}$ band) | | | | non-hot-start.** |
- | | | | | Redesign primers. |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- | **6. False | Passed | **FAILED** | Passed | **AMPLICON |
- | Positive in NTC** | | **(Product band | | CARRYOVER.** |
- | (Contamination) | | **present in NTC)**| | Discard reagents; |
- | | | | | 10% bleach, UNG. |
- +-------------------+-------------------+-------------------+-------------------+-------------------+
- 5. Laboratory Contamination Control & The dUTP/UNG System
Because PCR amplifies target sequences by > 10 9 >10^9 > 1 0 9 -fold, aerosolized amplicons from previous runs represent the single greatest threat to clinical assay specificity, causing catastrophic false-positive results . THE dUTP / UNG DECONTAMINATION SYSTEM
- [ Previous PCR Products (Contain Uracil instead of Thymine) ]
- |
- v Pre-PCR Incubation at 50°C for 2 min
- [ Uracil-N-Glycosylase (UNG / UDG) ]
- |
- v Excises Uracil bases -> Creates Abasic (AP) Sites
- [ Damaged Amplicon with Apyrimidic Sites ]
- |
- v Initial Denaturation at 95°C for 10 min
- [ Thermal Cleavage at AP Sites -> COMPLETE FRAGMENTATION ]
- [ UNG Enzyme is Heat-Inactivated -> Cannot Degrade Newly Formed PCR DNA ]
- |
- v
- [ ONLY Fresh Native Genomic DNA (Thymine-containing) Amplifies! ]
- The Biochemical Chemistry of Uracil-N-Glycosylase (UNG / UDG)
Substitution of dTTP with dUTP : In all routine PCR master mixes, deoxyuridine triphosphate (dUTP) is substituted for dTTP (either completely or as a 50:50 blend). Taq polymerase readily incorporates dUTP, generating uracil-containing PCR amplicons.
Pre-Amplification UNG Digestion : Before thermal cycling begins, the reaction is incubated at 50 ∘ C 50^\circ\text{C} 5 0 ∘ C for 2 – 5 minutes 2–5\text{ minutes} 2–5 minutes with Uracil-N-Glycosylase (UNG / UDG) (derived from E. coli or marine cod).
Uracil Base Excision : UNG specifically recognizes uracil in DNA (cleaving the N N N -glycosidic bond between the uracil base and the deoxyribose sugar ring), leaving abasic apyrimidinic (AP) sites .
Thermal Hydrolysis & UNG Inactivation : When the cycler heats to the initial denaturation temperature ( 95 ∘ C 95^\circ\text{C} 9 5 ∘ C for 10 minutes 10\text{ minutes} 10 minutes ):
High temperature breaks the phosphodiester backbone at abasic sites via β \beta β -elimination, fragmenting carryover amplicons into non-amplifiable pieces.
Standard E. coli UNG is permanently heat-inactivated at 95 ∘ C 95^\circ\text{C} 9 5 ∘ C , ensuring it does not destroy the newly synthesized uracil-containing amplicons produced during subsequent cycles.
Selectivity : Native clinical genomic DNA and viral targets contain thymine (not uracil) and are completely immune to UNG cleavage.
Architectural & Operational Contamination Safeguards
Strict Physical Unidirectional Workflow : Separate pre-PCR Area 1 (Reagent Preparation / Master Mix Setup), pre-PCR Area 2 (Specimen Extraction & DNA Addition), and post-PCR Area 3 (Thermal Cyclers, Gel Electrophoresis, Capillary Analyzers). Air flow must maintain positive pressure in Pre-PCR and negative pressure in Post-PCR.
Surface Decontamination : Daily cleaning with 10 % 10\% 10% household bleach (0.5% sodium hypochlorite) , which irreversibly breaks phosphodiester bonds, followed by 70 % 70\% 70% ethanol to remove corrosive chloride salts. Note: 70% ethanol alone precipitates DNA and does NOT eliminate amplicon contamination.